Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)

NCT05134974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Mydriasis
Dilation

Interventions

DRUG: Phentolamine Ophthalmic Solution 0.75%
DRUG: Phentolamine Ophthalmic Solution Vehicle

Sponsor

Ocuphire Pharma, Inc.